Meghan C. Thompson
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 19
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 11
-
- Chronic Myeloid Leukemia Treatments 6
- Acute Myeloid Leukemia Research 3
-
- CAR-T cell therapy research 5
-
- Injury Epidemiology and Prevention 4
- Acute Lymphoblastic Leukemia research 4
-
- Traffic and Road Safety 3
- Co-authors
- Anthony R. MatoHuiyun XiangGary A. SmithLindsey E. RoekerThiphalak ChounthirathChan Y. CheahChadi NabhanDavid A. Knorr
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Meghan C. Thompson
32 papers receiving 421 citations
Peers
Comparison fields: 5 of 58
- Genetics 203
- Pathology and Forensic Medicine 152
- Hematology 64
- Oncology 127
- Emergency Medicine 40
Countries citing papers authored by Meghan C. Thompson
This map shows the geographic impact of Meghan C. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghan C. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghan C. Thompson more than expected).
Fields of papers citing papers by Meghan C. Thompson
This network shows the impact of papers produced by Meghan C. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghan C. Thompson. The network helps show where Meghan C. Thompson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meghan C. Thompson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | SINGLE-AGENT EPCORITAMAB LEADS TO DEEP RESPONSES IN PATIENTS (PTS) WITH RICHTER’S TRANSFORMATION (RT): PRIMARY RESULTS FROM THE EPCORE CLL-1 TRIAL | 2024 | 1 |
| 5 | 2024 | 14 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 7 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 19 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 0 | |
| 14 | 2021 | 4 | |
| 15 | 2020 | 63 | |
| 16 | 2017 | 11 | |
| 17 | 2017 | 27 | |
| 18 | 2014 | 21 | |
| 19 | 2013 | 33 | |
| 20 | 2012 | 20 |
About Meghan C. Thompson
Meghan C. Thompson is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 36 papers that have together received 425 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (11 papers), Chronic Myeloid Leukemia Treatments (6 papers), CAR-T cell therapy research (5 papers), Injury Epidemiology and Prevention (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (3 papers) and Traffic and Road Safety (3 papers). The work is most often cited by research in Genetics (203 citations), Pathology and Forensic Medicine (152 citations) and Hematology (64 citations). Meghan C. Thompson has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Anthony R. Mato, Huiyun Xiang, Gary A. Smith, Lindsey E. Roeker, Thiphalak Chounthirath, Chan Y. Cheah, Chadi Nabhan, David A. Knorr, Melissa S. Pessin and Andrew D. Zelenetz. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.